# Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

> **NCT06385379** · NA · RECRUITING · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 90 (estimated)

## Conditions studied

- Aortic Arch Aneurysm

## Interventions

- **DEVICE:** WeFlow-Tribranch embedded aortic Triple-branch arch Stent Graft system

## Key facts

- **NCT ID:** NCT06385379
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06385379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06385379, "Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06385379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*